Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/11/1990 | US4976957 Process for the production of recognins and their chemoreciprocals |
12/11/1990 | CA1277614C Sialylated lewisx epitope, antibodies and diagnosis |
12/11/1990 | CA1277613C Monoclonal antibodies, a process for their preparation and their use |
12/11/1990 | CA1277612C Monoclonal antibodies with specificity for membrane- associated antigens |
12/08/1990 | CA2018453A1 Methods for enhancing the rate of modification of metastable bonds |
12/07/1990 | WO1990014841A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
12/07/1990 | WO1990014840A1 Recombinant alzheimer's amyloid protein |
12/07/1990 | CA2018248A1 Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
12/06/1990 | WO1990015078A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120 |
12/06/1990 | DE3915952A1 Medicaments for treating diseases involving intracellular protein - comprising nucleic acid coding for antibody to protein |
12/06/1990 | CA2058630A1 Human monoclonal antibodies to hiv-1 mn gp 120 |
12/06/1990 | CA2018297A1 Conjugate immunogen for aids |
12/05/1990 | EP0401055A2 Bone Calcification factor |
12/05/1990 | EP0401006A1 hANP antibody and method for immunological determination of hANP |
12/05/1990 | EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
12/05/1990 | EP0400245A1 Proteins and glycoproteins of the HIV-2 EHO retrovirus antiobodies directed against them - application for the diagnosis |
12/05/1990 | EP0400051A1 Polypeptide compounds having growth hormone releasing activity. |
12/05/1990 | EP0382736A4 Receptor membranes |
12/04/1990 | WO1990015073A1 Grf peptides |
12/04/1990 | US4975380 Chemiluminescent labeled organic reagents and their use in analysis of organic compounds |
12/04/1990 | US4975369 Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen |
12/04/1990 | CA2055619A1 Grf peptides |
12/04/1990 | CA1277262C Antibodies, manufacture and use |
12/04/1990 | CA1277261C Monoclonal antibodies and hybridoma cells, to humain reinin: processes for their preparation and their applications |
12/04/1990 | CA1277260C Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma |
12/03/1990 | WO1990015875A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
12/03/1990 | WO1990015149A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
12/03/1990 | WO1990015076A2 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
12/03/1990 | CA2056452A1 Protein having a transactivating property, vectors expressing this protein, cell lines, and uses thereof |
12/03/1990 | CA2055591A1 Vpt protein, vectors expressing this protein, cell products and assay methods |
12/02/1990 | WO1990015329A1 Monoclonal antibody specific to ventricular myosin light chain1 and enzyme immunoassay for its detection in cardiac patients |
12/02/1990 | CA2056407A1 Monoclonal antibody specific to ventricular myosin light chain1 and enzyme immunoassay for its detection in cardiac patients |
12/01/1990 | WO1990015140A1 Production of ibdv vp2 in highly immunogenic form |
12/01/1990 | WO1990014835A1 Method to treat rheumatoid arthritis |
12/01/1990 | CA2056450A1 Method to treat rheumatoid arthritis |
12/01/1990 | CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
11/30/1990 | CA2017933A1 Hanp antibody and method for immunological determination of hanp |
11/29/1990 | WO1990014443A1 Co-expression of heteromeric receptors |
11/29/1990 | WO1990014432A1 A human cytokine, interleukin-9 |
11/29/1990 | WO1990014430A1 A new method for tapping the immunological repertoire |
11/29/1990 | WO1990014427A2 Multivalent repressor of gene function |
11/29/1990 | WO1990014424A1 Method for isolating receptors having a preselected specificity |
11/29/1990 | WO1990014418A1 Heparin-producing murine mastocytoma cell lines |
11/29/1990 | WO1990014363A1 Metalloproteinase inhibitor |
11/29/1990 | WO1990014351A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor |
11/29/1990 | WO1990014104A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
11/29/1990 | WO1990014103A1 Polypeptide-antibody conjugate for inhibiting cell adhesion |
11/29/1990 | WO1990014069A2 Keratinocyte autocrine factor |
11/29/1990 | CA2057923A1 Co-expression of heteromeric receptors |
11/29/1990 | CA2054764A1 Hematopoietic growth factor derived form t lymphocytes and methods of use therefor |
11/28/1990 | EP0399777A2 Hematopoietic growth factor derived from T lymphocytes and methods of use therefor |
11/28/1990 | EP0399429A1 Anti-human interleukin-6 monoclonal antibody |
11/28/1990 | EP0399328A1 Teico-resistance conferring sequence |
11/28/1990 | EP0399271A2 Method for the detection of disease |
11/28/1990 | EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody |
11/28/1990 | EP0399024A1 ANTI-INTERLEUKINE 1$g(a) AND 1$g(b) MONOCLONAL ANTIBODIES, METHOD FOR PRODUCING THE SAME AND APPLICATIONS OF SAID ANTIBODIES TO THE DETECTION OF INTERLEUKINES 1$g(a) AND 1$g(b) AND TO THERAPY |
11/28/1990 | EP0398955A1 Diagnosis of retinoblastoma |
11/28/1990 | CN1047340A Therapeutic agent |
11/27/1990 | US4973669 Immunoglobulins, immunoassay, purification |
11/27/1990 | US4973666 Measurement of bone resorption rates, hydroxypyridinium crosslinks |
11/27/1990 | US4973556 Monoclonal antibodies to interferon alpha2 and hybridomas producing such antibodies |
11/27/1990 | US4973555 Human serine protease gene |
11/27/1990 | CA1277100C Glycopeptides, process for their preparation and their use |
11/27/1990 | CA1276884C2 Protein antibody derived from serum of a bovid |
11/27/1990 | CA1276883C2 Protein antibody composition derived from bovid milk and from avian egg |
11/26/1990 | WO1990014595A1 Composition and method to detect sensitivity to alpha interferon therapy |
11/26/1990 | WO1990014359A1 Biologically active polypeptides based on transforming growth factor-beta sequences |
11/26/1990 | CA2058420A1 Composition and method to detect sensitivity to alpha-interferon therapy |
11/25/1990 | WO1990014433A1 Monoclonal antibodies which recognise malignant cells from bladder carcinomas |
11/25/1990 | WO1990014361A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
11/25/1990 | CA2033202A1 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
11/23/1990 | CA2017234A1 Teico-resistance conferring sequence |
11/22/1990 | EP0398753A2 Metalloproteinase inhibitor |
11/22/1990 | EP0398707A1 Treatment and diagnosis of human lymphotropic viruses |
11/22/1990 | EP0398621A2 Immunoassay of elastase-1 |
11/22/1990 | EP0398327A1 Tumor necrosis factor binding protein II, its purification and antibodies thereto |
11/22/1990 | EP0398024A1 Conjugates for tumor localization and/or tumortherapy |
11/22/1990 | EP0397834A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
11/22/1990 | EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment |
11/22/1990 | EP0397798A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
11/22/1990 | EP0397764A1 Method of reducing immunoglobulin e responses |
11/20/1990 | WO1990014431A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
11/20/1990 | WO1990014422A1 Ribosomal frameshift signals and uses |
11/20/1990 | US4971794 Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili |
11/20/1990 | US4971792 Antitumor agents, anticarcinogenic agents, administering |
11/20/1990 | CA2057908A1 Fusion proteins having an in vivo post-translational modification site and methods of manufacture and purification |
11/20/1990 | CA2057865A1 Ribosomal frameshift signals and uses |
11/20/1990 | CA1276574C Monoclonal antibodies to activated platelets |
11/20/1990 | CA1276552C Conjugate vaccine against infections by gram-negative bacteria, method for its preparation and use |
11/19/1990 | CA2434741A1 Metalloproteinase inhibitor |
11/18/1990 | WO1990014360A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
11/18/1990 | CA2458875A1 Tumor necrosis factor (tnf) binding protein ii, its purification and antibodies thereto |
11/18/1990 | CA2056981A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
11/18/1990 | CA2014703A1 Immunoassay of elastase-1 |
11/17/1990 | CA2016962A1 Polypeptide-antibody conjugate for inhibiting cell adhesion |
11/16/1990 | WO1990014358A1 T-lymphotropic retrovirus monoclonal antibodies |
11/16/1990 | CA2032509A1 T-lymphotropic retrovirus monoclonal antibodies |
11/16/1990 | CA2016842A1 Method for tapping the immunological repertoire |
11/16/1990 | CA2016830A1 Methods for screening monoclonal antibodies for therapeutic use |
11/15/1990 | WO1990013670A1 Methods and systems for determining the presence of a pneumocystis carinii antigen in blood |